Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net loss	$ (21,158)	$ (3,256)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	552	1,116
Stock-based compensation	3,631	4,320
Non-cash lease expense	193	164
Accretion of discount on marketable debt securities	(1,157)	(1,288)
Changes in operating assets and liabilities:
Accounts receivable		(8,000)
Prepaid expenses and other current assets	(930)	(2,046)
Accounts payable	(2,013)	(1,365)
Accrued expenses and other current liabilities	(1,315)	(2,143)
Operating lease liabilities	(338)	(552)
Deferred revenues		(7,660)
Net cash used in operating activities	(22,535)	(20,710)
Investing activities
Redemption of marketable debt securities	67,173	74,532
Purchase of marketable debt securities	(51,352)	(92,793)
Purchase of property and equipment		(237)
Net cash provided by (used in) investing activities	15,821	(18,498)
Financing activities
Proceeds from issuance of common stock and pre-funded warrants in private placement, net of offering costs	2	46,872
Proceeds from issuance of common stock pursuant to ATM program, net of offering costs		10,590
Tax withholding payments related to net settlement of restricted common stock	(2)	(196)
Proceeds from the exercise of stock options		245
Net cash provided by financing activities		57,511
Net (decrease) increase in cash, cash equivalents and restricted cash	(6,714)	18,303
Cash, cash equivalents and restricted cash at beginning of year	20,945	11,136
Cash, cash equivalents and restricted cash at end of period	14,231	29,439
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	12,759	27,967
Restricted cash	1,472	1,472
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 14,231	$ 29,439